Effects of cancer screening restart strategies after COVID-19 disruption

Autor: Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Sylvia Kaljouw, Elisabeth F. P. Peterse, L. De Jonge, I. M. C. M. de Kok, Erik E.L. Jansen, N. T. van Ravesteyn, Lindy M. Kregting

Publikováno v: British Journal of Cancer
European Journal of Cancer
British Journal of Cancer, 124(9), 1516-1523. Nature Publishing Group
Web of Science

Background Many breast, cervical, and colorectal cancer screening programmes were disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five restart strategies after the disruption on required screening capacity and canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c5964eb1d25592a0e9f111f6092364
https://pure.eur.nl/en/publications/71927b11-737b-4eaa-9899-d6377fd17221

Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands

Autor: T M, Ripping, A L M, Verbeek, J, Fracheboud, H J, de Koning, N T, van Ravesteyn, M J M, Broeders

Publikováno v: International journal of cancer. 137(4)

A drawback of early detection of breast cancer through mammographic screening is the diagnosis of breast cancers that would never have become clinically detected. This phenomenon, called overdiagnosis, is ideally quantified from the breast cancer inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9d1965179801365f8d094cbbd91e647e
https://pubmed.ncbi.nlm.nih.gov/25612892